AIPLA 2020 Virtual Annual Meeting
October 22 to 30, 2020
Location
AIPLA Annual Meeting goes VIRTUAL
July 14, 2020. Given the current pandemic, the spike in COVID-19 cases in recent weeks, related governmental orders, guidance from the World Health Organization and the CDC about social distancing and avoiding large gatherings, we find ourselves again having to make the difficult decision to move away from an in-person conference for AIPLA’s 2020 Annual Meeting. Instead, we are announcing that this year’s AIPLA Annual Meeting will go virtual!We were able to successfully host the Spring Meeting as a virtual conference, and we will offer a stellar virtual experience for everyone in October. The Professional Programs Committee has again put together an excellent line-up of educational offerings. In addition to those programs, we are developing creative online networking events, informal meet-ups to discuss programs, and the ability to arrange one-on-one connections with meeting attendees. Building on our momentum and experience of the Spring Meeting, and benefiting from the advancements in online learning technology, the Annual Meeting promises to be even better than our successful Virtual Spring Meeting. We will provide updated information about plans for the virtual Annual Meeting as soon as possible.
AIPLA continues to look for ways to support you and provide you effective and rewarding ways to connect with your colleagues and friends in the AIPLA community during this unusual and challenging time. Look for our upcoming virtual events, webinars, committee conference calls, and other virtual meetings to stay connected and up-to-date on IP law and practice.
Please let us know if you have ideas for activities, virtual meetings or other events with members of the AIPLA community that could deepen our support of and ties with each other. As we have already shown through this pandemic, I am confident that we can continue to find ways to strengthen the AIPLA community we share.
Thank you for your continued support of the Association and of each other as we face these professional and personal challenges together.
Sponsorship Opportunities - We will be updating information soon on opportunities for sponsors and exhibitors soon!
Sponsors
Platinum
Gold
Silver
.tmb-medium.jpg?Culture=en&sfvrsn=6028ddce_1 "Oshal Liang (002)")
Bronze
5830f6b3544b43cd94cada5e425816da.tmb-medium.png?Culture=en&sfvrsn=9ec2aae6_1 "Wenderoth Logo (4)"){kind=logo}
Crystal
News
-
AIPLA Comments to the Copyright Office on Alternative Fee Structures for Registration
July 6, 2026
Alexandria, VA. June 24, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the U.S. Copyright Office's Notice of Inquiry regarding alternative copyright registration fee structures. -
AIPLA Comments to the Copyright Office on Group Registration of Updates to a News Website
July 6, 2026
Alexandria, VA. June 29, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments supporting the U.S. Copyright Office's proposed expansion of eligibility for group registration of updates to news websites by removing restrictions that exclude subject-specific publications. -
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry.